Index
1 Market Overview of Cardiac Safety Services
1.1 Cardiac Safety Services Market Overview
1.1.1 Cardiac Safety Services Product Scope
1.1.2 Cardiac Safety Services Market Status and Outlook
1.2 Global Cardiac Safety Services Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cardiac Safety Services Market Size by Region (2018-2029)
1.4 Global Cardiac Safety Services Historic Market Size by Region (2018-2023)
1.5 Global Cardiac Safety Services Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cardiac Safety Services Market Size (2018-2029)
1.6.1 North America Cardiac Safety Services Market Size (2018-2029)
1.6.2 Europe Cardiac Safety Services Market Size (2018-2029)
1.6.3 Asia-Pacific Cardiac Safety Services Market Size (2018-2029)
1.6.4 Latin America Cardiac Safety Services Market Size (2018-2029)
1.6.5 Middle East & Africa Cardiac Safety Services Market Size (2018-2029)
2 Cardiac Safety Services Market by Type
2.1 Introduction
2.1.1 Integrated Services
2.1.2 Standalone Services
2.2 Global Cardiac Safety Services Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cardiac Safety Services Historic Market Size by Type (2018-2023)
2.2.2 Global Cardiac Safety Services Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cardiac Safety Services Revenue Breakdown by Type (2018-2029)
3 Cardiac Safety Services Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biopharmaceuticals Companies
3.1.2 Contract Research Organization(CRO)
3.1.3 Others
3.2 Global Cardiac Safety Services Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cardiac Safety Services Historic Market Size by Application (2018-2023)
3.2.2 Global Cardiac Safety Services Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cardiac Safety Services Revenue Breakdown by Application (2018-2029)
4 Cardiac Safety Services Competition Analysis by Players
4.1 Global Cardiac Safety Services Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cardiac Safety Services as of 2022)
4.3 Date of Key Players Enter into Cardiac Safety Services Market
4.4 Global Top Players Cardiac Safety Services Headquarters and Area Served
4.5 Key Players Cardiac Safety Services Product Solution and Service
4.6 Competitive Status
4.6.1 Cardiac Safety Services Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Biotrial
5.1.1 Biotrial Profile
5.1.2 Biotrial Main Business
5.1.3 Biotrial Cardiac Safety Services Products, Services and Solutions
5.1.4 Biotrial Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.1.5 Biotrial Recent Developments
5.2 Banook Group
5.2.1 Banook Group Profile
5.2.2 Banook Group Main Business
5.2.3 Banook Group Cardiac Safety Services Products, Services and Solutions
5.2.4 Banook Group Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.2.5 Banook Group Recent Developments
5.3 Bioclinica
5.3.1 Bioclinica Profile
5.3.2 Bioclinica Main Business
5.3.3 Bioclinica Cardiac Safety Services Products, Services and Solutions
5.3.4 Bioclinica Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.3.5 Certara L.P. Recent Developments
5.4 Certara L.P.
5.4.1 Certara L.P. Profile
5.4.2 Certara L.P. Main Business
5.4.3 Certara L.P. Cardiac Safety Services Products, Services and Solutions
5.4.4 Certara L.P. Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.4.5 Certara L.P. Recent Developments
5.5 Celerion, Inc
5.5.1 Celerion, Inc Profile
5.5.2 Celerion, Inc Main Business
5.5.3 Celerion, Inc Cardiac Safety Services Products, Services and Solutions
5.5.4 Celerion, Inc Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.5.5 Celerion, Inc Recent Developments
5.6 ERT, Inc
5.6.1 ERT, Inc Profile
5.6.2 ERT, Inc Main Business
5.6.3 ERT, Inc Cardiac Safety Services Products, Services and Solutions
5.6.4 ERT, Inc Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.6.5 ERT, Inc Recent Developments
5.7 Laboratory Corporation of America Holdings
5.7.1 Laboratory Corporation of America Holdings Profile
5.7.2 Laboratory Corporation of America Holdings Main Business
5.7.3 Laboratory Corporation of America Holdings Cardiac Safety Services Products, Services and Solutions
5.7.4 Laboratory Corporation of America Holdings Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.7.5 Laboratory Corporation of America Holdings Recent Developments
5.8 Medpace Holdings, Inc.
5.8.1 Medpace Holdings, Inc. Profile
5.8.2 Medpace Holdings, Inc. Main Business
5.8.3 Medpace Holdings, Inc. Cardiac Safety Services Products, Services and Solutions
5.8.4 Medpace Holdings, Inc. Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.8.5 Medpace Holdings, Inc. Recent Developments
5.9 Ncardia AG
5.9.1 Ncardia AG Profile
5.9.2 Ncardia AG Main Business
5.9.3 Ncardia AG Cardiac Safety Services Products, Services and Solutions
5.9.4 Ncardia AG Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.9.5 Ncardia AG Recent Developments
5.10 Richmond Pharmacology
5.10.1 Richmond Pharmacology Profile
5.10.2 Richmond Pharmacology Main Business
5.10.3 Richmond Pharmacology Cardiac Safety Services Products, Services and Solutions
5.10.4 Richmond Pharmacology Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.10.5 Richmond Pharmacology Recent Developments
5.11 PhysioStim
5.11.1 PhysioStim Profile
5.11.2 PhysioStim Main Business
5.11.3 PhysioStim Cardiac Safety Services Products, Services and Solutions
5.11.4 PhysioStim Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.11.5 PhysioStim Recent Developments
5.12 IQVIA
5.12.1 IQVIA Profile
5.12.2 IQVIA Main Business
5.12.3 IQVIA Cardiac Safety Services Products, Services and Solutions
5.12.4 IQVIA Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.12.5 IQVIA Recent Developments
5.13 BioTelemetry, Inc
5.13.1 BioTelemetry, Inc Profile
5.13.2 BioTelemetry, Inc Main Business
5.13.3 BioTelemetry, Inc Cardiac Safety Services Products, Services and Solutions
5.13.4 BioTelemetry, Inc Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.13.5 BioTelemetry, Inc Recent Developments
5.14 Pharmaceutical Product Development, LLC
5.14.1 Pharmaceutical Product Development, LLC Profile
5.14.2 Pharmaceutical Product Development, LLC Main Business
5.14.3 Pharmaceutical Product Development, LLC Cardiac Safety Services Products, Services and Solutions
5.14.4 Pharmaceutical Product Development, LLC Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.14.5 Pharmaceutical Product Development, LLC Recent Developments
5.15 Shanghai Medicilon Inc
5.15.1 Shanghai Medicilon Inc Profile
5.15.2 Shanghai Medicilon Inc Main Business
5.15.3 Shanghai Medicilon Inc Cardiac Safety Services Products, Services and Solutions
5.15.4 Shanghai Medicilon Inc Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.15.5 Shanghai Medicilon Inc Recent Developments
5.16 SGS SA
5.16.1 SGS SA Profile
5.16.2 SGS SA Main Business
5.16.3 SGS SA Cardiac Safety Services Products, Services and Solutions
5.16.4 SGS SA Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.16.5 SGS SA Recent Developments
5.17 Spaulding Clinical Research, LLC
5.17.1 Spaulding Clinical Research, LLC Profile
5.17.2 Spaulding Clinical Research, LLC Main Business
5.17.3 Spaulding Clinical Research, LLC Cardiac Safety Services Products, Services and Solutions
5.17.4 Spaulding Clinical Research, LLC Cardiac Safety Services Revenue (US$ Million) & (2018-2023)
5.17.5 Spaulding Clinical Research, LLC Recent Developments
6 North America
6.1 North America Cardiac Safety Services Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cardiac Safety Services Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cardiac Safety Services Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cardiac Safety Services Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cardiac Safety Services Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cardiac Safety Services Market Dynamics
11.1 Cardiac Safety Services Industry Trends
11.2 Cardiac Safety Services Market Drivers
11.3 Cardiac Safety Services Market Challenges
11.4 Cardiac Safety Services Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List